Similarly, semaglutide for weight loss is titrated to a target subcutaneous dose of 2.4 mg/week, while its oral formulation -approved for T2DM management- is administered at 314 mg/day [39]
The American journal of clinical nutrition , 102 3, 548-55
Semaglutide has several effects on the body, including: Increasing how much insulin the pancreas makes and releases into the bloodstream helps lower blood sugar (glucose) when it is high Blocking the body from making glucagon, a hormone that increases blood sugar Slowing the emptying of the stomach, helping you feel full quicker and longer Interacting with parts of the brain to reduce appetite and signal to the body that you're full Semaglutide was originally developed to lower blood glucose in people living with type 2 diabetes
Coverage of weight management medications may also help with employee retention and recruitment
Key Points Semaglutide (Ozempic, Wegovy) works by targeting one hormone (GLP-1), while tirzepatide (Mounjaro, Zepbound) targets two hormones (GLP-1 and GIP) for a dual-action effect
Proper injection technique is crucial for both medication effectiveness and patient safety